基于MAP3K3通路干预PD-L1表达探讨LBP在改善肺腺癌免疫抑制微环境中的作用
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | CSE1L silencing impairs tumor progression viaMET/STAT3/PD-L1 signaling in lung cancer. | 期刊论文 | Weijun Liu;Zhiqing Zhou;Yu Li;Jiali Xu;Yang Shen;Suisui Luo;Yujie Zhou;Xing Wu;Huijie Zhao;David G Beer;Yanli He;Guoan Chen |
2 | MAP3K3基因过表达通过多条信号通路激活CREB 促进人肺腺癌细胞增殖及上皮-间质转化 | 期刊论文 | 郭振辉;茆文莉;陈文雅;梁娇;侯聪艳;张韧;何彦丽 |
3 | Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation | 期刊论文 | Zhenhui Guo;Heng Yin;Tong Wu;Shaofeng Wu;Lingyun Liu;Lei Zhang;Yanli He;Ren Zhang;Na Liu |
4 | Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma | 期刊论文 | Wenli Mao;Heng Yin;Wenya Chen;Tingxiu Zhao;Shaofeng Wu;He Jin;Biaoyan Du;Yuhui Tan;Ren Zhang;Yanli He |